ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Can NCI Fund 4-Year Grants With 2-Year Stimulus Funds?

March 6, 2009

Obituaries: Fritz Bach, 77, and William Wolff, 94

September 9, 2011

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

Coalition Of Cooperative Groups Lists High Priority Trials In Breast Cancer.

October 17, 2008

FDA, HCFA Form Council On Biomedical Imaging.

November 10, 2000

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976